57. Idiopathic dilated cardiomyopathy Clinical trials / Disease details

Clinical trials : 11 / Drugs : 23 - (DrugBank : 12) / Drug target genes : 9 - Drug target pathways : 35

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01302171 (ClinicalTrials.gov)	August 2010	21/2/2011	Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy	Randomised Controlled Trial to Compare the Effects of G-CSF (Granocyte™) and Autologous Bone Marrow Progenitor Cells on Quality of Life and Left Ventricular Function in Patients With Idiopathic Dilated Cardiomyopathy	Dilated Cardiomyopathy	Drug: granulocyte colony stimulating factor (GCSF);Procedure: bone marrow mononuclear cells	Barts & The London NHS Trust	Royal Brompton & Harefield NHS Foundation Trust;University College London Hospitals	Completed	18 Years	80 Years	Both	60	Phase 2	United Kingdom
2	EUCTR2009-013112-12-GB (EUCTR)	22/04/2010	17/03/2010	Randomised Controlled Trial To Compare The effects of G-CSF(Granocyte™) And Autologous Bone Marrow Progenitor Cells On Quality Of Life And Left Ventricular Function In Patients with Idiopathic Dilated Cardiomyopathy - REGENERATE-DCM	Randomised Controlled Trial To Compare The effects of G-CSF(Granocyte™) And Autologous Bone Marrow Progenitor Cells On Quality Of Life And Left Ventricular Function In Patients with Idiopathic Dilated Cardiomyopathy - REGENERATE-DCM	Idiopathic Dilated Cardiomyopathy Level: LLTClassification code 10056419Term: Dilated Cardiomyopathy	Trade Name: Granocyte Lenograstim Product Name: GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF) Product Code: PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION)	Barts & the London NHS Trust	NULL	Not Recruiting			Female: yes Male: yes			United Kingdom